GYEMSZI - MOB

Heimesaat, Markus M. - Kapcsolódó tételek

1.			Absinthe against multi-drug resistant bacterial pathogens? : a recent update on the antibacterial effects of Artemisia compounds
2.			Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria
3.			Antibacterial effects of sulforaphane - A phytonutrient derived from broccoli as promising candidate in the combat of bacterial infections
4.			Antibacterial effects of vanilla ingredients provide novel treatment options for infections with multidrug-resistant bacteria - A recent literature review
5.			Antibacterial properties of capsaicin and its derivatives and their potential to fight antibiotic resistance - A literature survey
6.			Anti-inflammatory effects of the octapeptide NAP in human microbiota-associated mice suffering from subacute ileitis
7.			Anti-Inflammatory Properties of NAP in Acute Toxoplasma gondii-Induced Ileitis in Mice
8.			Antimicrobial and Immune-Modulatory Effects of Vitamin D Provide Promising Antibiotics-Independent Approaches to Tackle Bacterial Infections - Lessons Learnt from a Literature Survey
9.			Binary surrogate endpoints in clinical trials from the perspective of case definitions
10.			Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam
11.			Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni?
12.			Carvacrol prophylaxis improves clinical outcome and dampens apoptotic and pro-inflammatory immune responses upon Campylobacter jejuni infection of human microbiota-associated IL-10-/- mice
13.			Changes of the intestinal microbiome-host homeostasis in HIV-infected individuals - a focus on the bacterial gut microbiome
14.			Chronic otitis media following infection by non-O1/non-O139 Vibrio cholerae: A case report and review of the literature
15.			Colonic Expression of Genes Encoding Inflammatory Mediators and Gelatinases During Campylobacter Jejuni Infection of Conventional Infant Mice
16.			Colonization resistance against genetically modified Escherichia coli K12 (W3110) strains is abrogated following broad-spectrum antibiotic treatment and acute ileitis
17.			Come to the dark side - A review on the health-beneficial and disease-alleviating effects of cocoa-rich dark chocolate
18.			Commensal microbiota drive proliferation of conventional and Foxp3+ Regulatory CD4+ T cells in mesenteric lymph nodes and Peyer's patches
19.			Comprehensive survey of intestinal microbiota changes in offspring of human microbiota associated mice
20.			The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
21.			Differential antibiosis predisposes mice to Campylobacter jejuni infection: Deeper insights into the impact of the gut microbiota composition in colonization resistance
22.			Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models
23.			Distinct antibiotic treatment regimens differentially affect colonization resistance against multi-drug resistant Pseudomonas aeruginosa in mice
24.			Ethnic disparities in prevalence and screening rates of sexually transmitted infections
25.			Evaluation of the Xiamen AmonMed Biotechnology rapid diagnostic test COVID-19 IgM/IgG test kit (Colloidal gold)
26.			Fecal Microbiota Transplantation Decreases Intestinal Loads of Multi-Drug Resistant Pseudomonas aeruginosa in Murine Carriers
27.			Finding novel antibiotic substances from medicinal plants - Antimicrobial properties of Nigella sativa directed against multidrug resistant bacteria
28.			Function of serine protease HtrA in the lifecycle of the foodborne pathogen Campylobacter jejuni
29.			Human microbiota associated IL-10-/- mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
30.			Immunomodulatory and Antimicrobial Effects of Vitamin C
31.			The impact of ketogenic diet on the onset and progression of multiple sclerosis
32.			Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract
33.			Infections acquired in barbershops - A review
34.			Intestinal expression of genes encoding inflammatory mediators and gelatinases during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice
35.			Intestinal microbiota changes in mice lacking pituitary adenylate cyclase activating polypeptide (PACAP) - bifidobacteria make the difference
36.			A literature survey on antimicrobial and immune-modulatory effects of butyrate revealing non-antibiotic approaches to tackle bacterial infections
37.			Matrix Metalloproteinase-2 Mediates Intestinal Immunopathogenesis in Campylobacter jejuni-infected infant mice
38.			Microbiota composition and immune responses during Campylobacter jejuni infection in conventionally colonized IL-10-/- mice lacking nucleotide oligomerization domain 2
39.			Microbiota composition and inflammatory immune responses upon peroral application of the commercial competitive exclusion product Aviguard(R) to microbiota-depleted wildtype mice
40.			Modulation of the intestinal microbiota impacts the efficacy of immunotherapy in cancer patients - A recent literature survey
41.			Multidrug-resistant Pseudomonas aeruginosa induce systemic pro-inflammatory immune responses in colonized mice
42.			Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
43.			Oral application of carvacrol, butyrate, ellagic acid, and 2'-fucosyl-lactose to mice suffering from acute campylobacteriosis - Results from a preclinical placebo-controlled intervention study
44.			Peroral low-dose Toxoplasma gondii infection of human microbiota-associated mice - a subacute ileitis model to unravel pathogen-host interactions
45.			Phage therapy in lung infections caused by multidrug-resistant Pseudomonas aeruginosa - A literature review
46.			Phage therapy in prosthetic joint infections caused by Staphylococcus aureus - A literature review
47.			Polyphenolic compounds in the combat of foodborne infections - An update on recent evidence
48.			Prophylactic oral application of resveratrol to alleviate acute campylobacteriosis in human gut microbiota associated IL-10-/- mice
49.			Recent evidence on prominent anti-bacterial capacities of compounds derived from the mangosteen fruit
50.			A recent update on the antibacterial effects of distinct bioactive molecules derived from the Cannabis plant

Mind kijelölve: